These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19756593)

  • 1. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
    Cathro HP; Smolkin ME; Theodorescu D; Jo VY; Ferrone S; Frierson HF
    Cancer Immunol Immunother; 2010 Mar; 59(3):465-72. PubMed ID: 19756593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
    Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
    Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
    PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
    Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
    Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
    Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
    Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
    Tourkova IL; Shurin GV; Chatta GS; Perez L; Finke J; Whiteside TL; Ferrone S; Shurin MR
    J Immunol; 2005 Sep; 175(5):3045-52. PubMed ID: 16116192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome.
    Tertipis N; Haeggblom L; Grün N; Nordfors C; Näsman A; Dalianis T; Ramqvist T
    Transl Oncol; 2015 Feb; 8(1):10-7. PubMed ID: 25749172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
    Davick JJ; Frierson HF; Smolkin M; Gru AA
    Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
    Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
    Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-related antigen-processing machinery component defects in feline mammary carcinoma.
    Favole A; Cascio P; Cerruti F; Sereno A; Tursi M; Tomatis A; Della Beffa C; Ferrone S; Bollo E
    Transl Oncol; 2012 Feb; 5(1):48-55. PubMed ID: 22348176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.